Metabolic tumor burden as a prognostic indicator after neoadjuvant chemotherapy in pancreatic cancer
Lists
Only you see this
Abstract
Elevated MTV is an influential prognostic factor for worse survival, regardless of post-NAT CA19-9 levels. These results could be helpful in identifying patients with a poor prognosis despite normalization of CA19-9 levels after NAT.
BibTeX
@article{lee2024metabolic,
author = {Woohyung Lee and Minyoung Oh and Jae Seung Kim and Minkyu Sung and Kwangpyo Hong and Bong Jun Kwak and Yejong Park and Eunsung Jun and Ki Byung Song and Dae Wook Hwang and Jae Hoon Lee and Changhoon Yoo and Kyu‐pyo Kim and Inkeun Park and Jae Ho Jeong and Heung-Moon Chang and Baek‐Yeol Ryoo and Jung Bok Lee and Song Cheol Kim},
title = {{Metabolic tumor burden as a prognostic indicator after neoadjuvant chemotherapy in pancreatic cancer}},
journal = {International Journal of Surgery},
year = {2024},
doi = {10.1097/js9.0000000000001389},
}Loading related content...